Word

SYMPHONX

Status

Registered

Status Code

700

Status Date

Tuesday, June 7, 2022

Serial Number

79302302

Registration Number

6749084

Registration Date

Tuesday, June 7, 2022

Mark Type

4000

Filing Date

Thursday, July 9, 2020

Published for Opposition

Tuesday, March 22, 2022

Trademark Owner History

FUJIFILM Diosynth Biotechnologies UK Limited - Original Registrant

Classifications

40 Processing and manufacturing of biological products such as cells, viruses and biomolecules, including genes and proteins, namely, manufacturing of pharmaceuticals using biological organisms in the manufacturing process to the order and specification of others; Manufacture of biomolecules such as cells, viruses and biomolecules, including genes and proteins, to the order and specification of others

9 Fluid processing system for use in the separation and purification of biological products such as cells, viruses and biomolecules, including nucleic acids and proteins, for bioprocessing and pharmaceutical research, comprised primarily of chromatography apparatus for laboratory use, laboratory filters, and fluid handling devices used for bioprocessing applications and component parts and fittings; Liquid chromatography apparatus for laboratory use; Ion exchange chromatography apparatus for the treatment of fluids for laboratory use; Ultrafiltration apparatus for laboratory or scientific research use, namely, ultrafiltration laboratory filters and laboratory ultrafiltration filter membranes as part of scientific apparatus; Diafiltration apparatus for laboratory or scientific research use, namely, laboratory diafiltration filters; Scientific, laboratory, and measuring apparatus and instruments for diluting or concentrating biological products for laboratory or scientific research use, namely, tangential flow filtration devices for preparation of biological samples for use in the biopharmaceutical industry; Laboratory filters in the nature of viral filtration apparatus for removal of viruses from solutions for laboratory or scientific research use; Membrane filtration apparatus in the nature of membrane laboratory filters for use in laboratory equipment in the biopharmaceutical industry for treating biological fluids and solutions; Chromatography apparatus and component parts thereof for laboratory or scientific research use; Parts and fittings, namely, tubing, valves, in-line mixers, pressure sensors, temperature sensors and electronic sensors specially adapted for use with all of the aforementioned goods; Computer software for control of the aforesaid goods, namely, downloadable and recorded software for operating a fluid processing apparatus for laboratory or scientific research use comprising chromatography, membrane filtration, tangential flow filtration, viral filtration, ultrafiltration, diafiltration, viral filtration, viral inactivation, in-line conditioning, and buffer management components and systems; Computer software for management of biological product purification processes, namely, downloadable and recorded software for managing the purification of cells, viruses, and biomolecules in the nature of nucleic acids and proteins

11 Fluid processing system apparatus and system for use in the separation and purification of biological products such as cells, viruses and biomolecules, including nucleic acids and proteins, for the pharmaceutical and biomanufacturing industries, namely, chromatography apparatus for industrial use and apparatus and instruments for use in the purification, conditioning, separation and sterilization of liquids and gases used in the biotechnology, pharmaceutical, medical, and biopharmaceutical industries; Liquid chromatography apparatus for industrial purposes; Ion exchange apparatus for the treatment of fluids for industrial purposes; Ultrafiltration apparatus for industrial purposes, namely, apparatus and instruments for use in the purification, separation and sterilization of liquids and gases used in the biotechnology, pharmaceutical, medical, and biopharmaceutical industries; Diafiltration apparatus, namely, aqueous solution filtering systems and components and biological fluid filtering systems and components for industrial purposes being apparatus and instruments for use in the purification, separation and sterilization of liquids used in the biotechnology, pharmaceutical, medical, and biopharmaceutical industries; Apparatus for diluting or concentrating biological products for industrial purposes, namely, tangential flow filtration apparatus being apparatus for use in the purification, separation and sterilization of liquids and gases used in the biotechnology, pharmaceutical, medical, and biopharmaceutical industries; Viral filtration apparatus for removal of viruses from solutions for industrial purposes, namely, apparatus and instruments for use in the purification, separation and sterilization of liquids and gases used in the biotechnology, pharmaceutical, medical, and biopharmaceutical industries; Virus inactivation and disinfection apparatus for the treatment of biological products in the field of biomanufacturing and pharmaceuticals, all for industrial purposes in the nature of apparatus and instruments for use in the purification, separation and sterilization of liquids and gases used in the biotechnology, pharmaceutical, medical, and biopharmaceutical industries; Membrane filtration apparatus for industrial purposes in the nature of membrane filter cartridges for the separation of biomolecules in biopharmaceutical production; Chromatography apparatus for industrial purposes and component parts thereof; Parts and fittings, namely, tubing, valves, in-line mixers, pressure sensors, temperature sensors and electric sensors, specially adapted for use with the aforementioned

42 Scientific research, industrial biomedical research and technical product research and development services in the field of biomanufacturing, bioprocessing and pharmaceuticals related to biological products such as cells, viruses and biomolecules, including nucleic acids and proteins; Process development services related to the manufacture and purification of biological products such as such as cells, viruses and biomolecules, including nucleic acids and proteins, namely, biomedical and pharmaceutical research; Industrial design services related to the manufacture and purification of biological products such as cells, viruses and biomolecules, including nucleic acids and proteins; Provision of facilities for scientific, industrial and technical research and development in the field of biomanufacturing, bioprocessing and pharmaceuticals, namely, scientific laboratory services

Trademark Events

Feb 16, 2024

New Representative At Ib Received

Oct 25, 2022

Final Decision Transaction Processed By Ib

Sep 19, 2022

Generic Madrid Transaction Sent To Ib

Sep 19, 2022

Generic Madrid Transaction Created

Sep 7, 2022

Final Disposition Notice Created, To Be Sent To Ib

Jun 7, 2022

Notice Of Registration Confirmation Emailed

Jun 7, 2022

Registered-Principal Register

Mar 27, 2022

Notification Processed By Ib

Mar 22, 2022

Official Gazette Publication Confirmation E-Mailed

Mar 22, 2022

Published For Opposition

Mar 2, 2022

Notification Of Possible Opposition Sent To Ib

Mar 2, 2022

Notice Of Start Of Opposition Period Created, To Be Sent To Ib

Mar 2, 2022

Notification Of Notice Of Publication E-Mailed

Feb 14, 2022

Law Office Publication Review Completed

Feb 14, 2022

Approved For Pub - Principal Register

Feb 14, 2022

Examiner's Amendment Entered

Feb 13, 2022

Assigned To Lie

Feb 11, 2022

Notification Of Examiners Amendment E-Mailed

Feb 11, 2022

Examiners Amendment E-Mailed

Feb 11, 2022

Examiners Amendment -Written

Aug 23, 2021

Notification Of Final Refusal Emailed

Aug 23, 2021

Final Refusal E-Mailed

Aug 23, 2021

Final Refusal Written

Aug 5, 2021

Teas/Email Correspondence Entered

Aug 5, 2021

Correspondence Received In Law Office

Aug 5, 2021

Teas Response To Office Action Received

Mar 1, 2021

Refusal Processed By Ib

Feb 5, 2021

Non-Final Action Mailed - Refusal Sent To Ib

Feb 5, 2021

Refusal Processed By Mpu

Jan 21, 2021

Non-Final Action (Ib Refusal) Prepared For Review

Jan 20, 2021

Non-Final Action Written

Jan 19, 2021

Application Filing Receipt Mailed

Jan 15, 2021

Assigned To Examiner

Jan 15, 2021

New Application Office Supplied Data Entered

Jan 14, 2021

Sn Assigned For Sect 66a Appl From Ib